Nautilus Biotechnology, Inc. (NAUT) Tops Q2 EPS by 3c

Nautilus Biotechnology, Inc. (NASDAQ: NAUT) reported Q2 EPS of ($0.12), $0.03 better than the analyst estimate of ($0.15).

For earnings history and earnings-related data on Nautilus Biotechnology, Inc. (NAUT) click here.

You May Also Be Interested In

• Amylyx Pharmaceuticals inc. (AMLX) PT Raised to $55 at Guggenheim
• Ameramex International, Inc. (AMMX) Reports In-Line Q2 EPS
• Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance